Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting

BACKGROUND: Respiratory syncytial virus (RSV) infects almost all children by the age of 2 years, with the risk of hospitalisation highest in the first 6 months of life. Development and licensure of a vaccine to prevent severe RSV illness in infants is a public health priority. A recent phase 3 clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Patricia T., Geard, Nicholas, Hogan, Alexandra B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661211/
https://www.ncbi.nlm.nih.gov/pubmed/33176774
http://dx.doi.org/10.1186/s12916-020-01783-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661211/
https://www.ncbi.nlm.nih.gov/pubmed/33176774
http://dx.doi.org/10.1186/s12916-020-01783-8

Ejemplares similares